Ligand Reports Third Quarter 2021 Financial Results
Go back to Ligand Reports Third Quarter 2021 Financial Results| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 293.27 +4.52 (1.57%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $288.75 | 52 Week High | $139.79 | |||
| Open | $290.38 | 52 Week Low | $82.07 | |||
| Day High | $294.75 | P/E | 682.02 | |||
| Day Low | $287.81 | EPS | $0.43 | |||
| Volume | 372,332 | |||||

